{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:23:38Z","timestamp":1792225418069,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1038\/s41375-019-0382-3","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T15:04:14Z","timestamp":1548342254000},"page":"1608-1619","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex"],"prefix":"10.1038","volume":"33","author":[{"given":"Luisa","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Heyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Scheiblecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0932-2052","authenticated-orcid":false,"given":"Thomas","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Frampton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Nerlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Grembecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4289-2281","authenticated-orcid":false,"given":"Florian","family":"Grebien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"382_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H D\u00f6hner","year":"2015","unstructured":"D\u00f6hner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373:1136\u201352.","journal-title":"N Engl J Med"},{"key":"382_CR2","doi-asserted-by":"publisher","unstructured":"Zhang Y, Wang F, Chen X, Liu W, Fang J, Wang M, et al. Mutation profiling of 16 candidate genes in de novo acute myeloid leukemia patients. Front Med. 2018; https:\/\/doi.org\/10.1007\/s11684-018-0616-1 .","DOI":"10.1007\/s11684-018-0616-1"},{"key":"382_CR3","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/leu.2013.273","volume":"28","author":"A Fasan","year":"2014","unstructured":"Fasan A, Haferlach C, Alpermann T, Jeromin S, Grossmann V, Eder C, et al. The role of different genetic subtypes of CEBPA mutated AML. Leukemia. 2014;28:794\u2013803.","journal-title":"Leukemia"},{"key":"382_CR4","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.18632\/oncotarget.23575","volume":"9","author":"JS Ahn","year":"2018","unstructured":"Ahn J-S, Kim H-J, Kim Y-K, Lee S-S, Ahn S-Y, Jung S-H, et al. Assessment of a new genomic classification system in acute myeloid leukemia with a normal karyotype. Oncotarget. 2018;9:4961\u20138.","journal-title":"Oncotarget"},{"key":"382_CR5","doi-asserted-by":"crossref","unstructured":"Hasemann MS, Lauridsen FKB, Waage J, Jakobsen JS, Frank AK, Schuster MB, et al. C\/EBP\u03b1 is required for long-term self-renewal and lineage priming of hematopoietic stem cells and for the maintenance of epigenetic configurations in multipotent progenitors. PLoS Genet. 2014;10:e1004079.","DOI":"10.1371\/journal.pgen.1004079"},{"key":"382_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/85820","volume":"27","author":"T Pabst","year":"2001","unstructured":"Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, et al. Dominant-negative mutations of CEBPA, encoding CCAAT\/enhancer binding protein-alpha (C\/EBP\u03b1), in acute myeloid leukemia. Nat Genet. 2001;27:263\u201370.","journal-title":"Nat Genet"},{"key":"382_CR7","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.immuni.2004.11.006","volume":"21","author":"P Zhang","year":"2004","unstructured":"Zhang P, Iwasaki-Arai J, Iwasaki H, Fenyus ML, Dayaram T, Owens BM, et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C\/EBP\u03b1. Immunity. 2004;21:853\u201363.","journal-title":"Immunity"},{"key":"382_CR8","doi-asserted-by":"publisher","first-page":"9606","DOI":"10.1073\/pnas.90.20.9606","volume":"90","author":"FT Lin","year":"1993","unstructured":"Lin FT, MacDougald OA, Diehl AM, Lane MD. A 30-kDa alternative translation product of the CCAAT\/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity. Proc Natl Acad Sci Usa. 1993;90:9606\u201310.","journal-title":"Proc Natl Acad Sci Usa"},{"key":"382_CR9","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.1038\/sj.onc.1210765","volume":"26","author":"T Pabst","year":"2007","unstructured":"Pabst T, Mueller BU. Transcriptional dysregulation during myeloid transformation in AML. Oncogene. 2007;26:6829\u201337.","journal-title":"Oncogene"},{"key":"382_CR10","doi-asserted-by":"crossref","first-page":"24970","DOI":"10.18632\/oncotarget.23873","volume":"9","author":"L Su","year":"2018","unstructured":"Su L, Tan Y, Lin H, Liu X, Yu L, Yang Y, et al. Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance. Oncotarget. 2018;9:24970\u20139.","journal-title":"Oncotarget"},{"key":"382_CR11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1200\/JCO.2008.17.9812","volume":"27","author":"S Koschmieder","year":"2009","unstructured":"Koschmieder S, Halmos B, Levantini E, Tenen DG. Dysregulation of the C\/EBP\u03b1 differentiation pathway in human cancer. J Clin Oncol. 2009;27:619\u201328.","journal-title":"J Clin Oncol"},{"key":"382_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nchembio.1859","volume":"11","author":"F Grebien","year":"2015","unstructured":"Grebien F, Vedadi M, Getlik M, Giambruno R, Grover A, Avellino R, et al. Pharmacological targeting of the Wdr5-MLL interaction in C\/EBP\u03b1 N-terminal leukemia. Nat Chem Biol. 2015;11:571\u20138.","journal-title":"Nat Chem Biol"},{"key":"382_CR13","doi-asserted-by":"crossref","unstructured":"Guarnaccia A duPuy, Tansey WP. Moonlighting with WDR5: a cellular multitasker. J Clin Med. 2018;7:21.","DOI":"10.3390\/jcm7020021"},{"key":"382_CR14","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1038\/leu.2010.171","volume":"24","author":"T Gan","year":"2010","unstructured":"Gan T, Jude CD, Zaffuto K, Ernst P. Developmentally induced Mll1 loss reveals defects in postnatal haematopoiesis. Leukemia. 2010;24:1732\u201341.","journal-title":"Leukemia"},{"key":"382_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1534-5807(04)00061-9","volume":"6","author":"P Ernst","year":"2004","unstructured":"Ernst P, Fisher JK, Avery W, Wade S, Foy D, Korsmeyer SJ. Definitive hematopoiesis requires the mixed-lineage leukemia gene. Dev Cell. 2004;6:437\u201343.","journal-title":"Dev Cell"},{"key":"382_CR16","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1182\/blood.V90.5.1799","volume":"90","author":"JL Hess","year":"1997","unstructured":"Hess JL, Yu BD, Li B, Hanson R, Korsmeyer SJ. Defects in yolk sac hematopoiesis in Mll-null embryos. Blood. 1997;90:1799\u2013806.","journal-title":"Blood"},{"key":"382_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.stem.2007.07.002","volume":"1","author":"KA McMahon","year":"2007","unstructured":"McMahon KA, Hiew SY-L, Hadjur S, Veiga-Fernandes H, Menzel U, Price AJ, et al. Mll has a critical role in fetal and adult hematopoietic stem cell self-renewal. Cell Stem Cell. 2007;1:338\u201345.","journal-title":"Cell Stem Cell"},{"key":"382_CR18","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1128\/MCB.01742-12","volume":"33","author":"R Nuland van","year":"2013","unstructured":"van Nuland R, Smits AH, Pallaki P, Jansen PWTC, Vermeulen M, Timmers HTM. Quantitative dissection and stoichiometry determination of the human SET1\/MLL histone methyltransferase complexes. Mol Cell Biol. 2013;33:2067\u201377.","journal-title":"Mol Cell Biol"},{"key":"382_CR19","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nsmb1128","volume":"13","author":"Y Dou","year":"2006","unstructured":"Dou Y, Milne TA, Ruthenburg AJ, Lee S, Lee JW, Verdine GL, et al. Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat Struct Mol Biol. 2006;13:713\u20139.","journal-title":"Nat Struct Mol Biol"},{"key":"382_CR20","first-page":"1","volume":"5","author":"F Cao","year":"2010","unstructured":"Cao F, Chen Y, Cierpicki T, Liu Y, Basrur V, Lei M, et al. An Ash2L\/RbBP5 heterodimer stimulates the MLL1 methyltransferase activity through coordinated substrate interactions with the MLL1 SET domain. PLoS ONE. 2010;5:1\u201311.","journal-title":"PLoS ONE"},{"key":"382_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cell.2005.09.025","volume":"123","author":"A Yokoyama","year":"2005","unstructured":"Yokoyama A, Somervaille TCP, Smith KS, Rozenblatt-Rosen O, Meyerson M, Cleary ML. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell . 2005;123:207\u201318.","journal-title":"Cell"},{"key":"382_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ccr.2008.05.003","volume":"14","author":"A Yokoyama","year":"2008","unstructured":"Yokoyama A, Cleary ML. Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell. 2008;14:36\u201346.","journal-title":"Cancer Cell"},{"key":"382_CR23","first-page":"95","volume":"131","author":"S El Ashkar","year":"2017","unstructured":"El Ashkar S, Schwaller J, Pieters T, Goossens S, Demeulemeester J, Christ F, et al. LEDGF\/p75 is dispensable for hematopoiesis but essential for MLL-rearranged leukemogenesis. Blood. 2017;131:95\u2013107.","journal-title":"Blood"},{"key":"382_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ccr.2008.02.008","volume":"13","author":"P Kirstetter","year":"2008","unstructured":"Kirstetter P, Schuster MB, Bereshchenko O, Moore S, Dvinge H, Kurz E, et al. Modeling of C\/EBP\u03b1 mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer Cell. 2008;13:299\u2013310.","journal-title":"Cancer Cell"},{"key":"382_CR25","first-page":"1304","volume":"28","author":"S He","year":"2016","unstructured":"He S, Calcagno C, Lobatto ME, Robson PM, Millon A, Grembecka J. Menin-MLL inhibitors block oncogenic transformation by MLL fusion proteins in a fusion independant manner. Leukemia. 2016;28:1304\u201314.","journal-title":"Leukemia"},{"key":"382_CR26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nchembio.773","volume":"8","author":"J Grembecka","year":"2012","unstructured":"Grembecka J, He S, Shi A, Purohit T, Muntean AG, Sorenson RJ, et al. Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia. Nat Chem Biol. 2012;8:277\u201384.","journal-title":"Nat Chem Biol"},{"key":"382_CR27","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1182\/blood-2012-05-429274","volume":"120","author":"A Shi","year":"2012","unstructured":"Shi A, Murai MJ, He S, Lund G, Hartley T, Purohit T, et al. Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leukemia. Blood. 2012;120:4461\u20139.","journal-title":"Blood"},{"key":"382_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ccell.2015.02.016","volume":"27","author":"D Borkin","year":"2015","unstructured":"Borkin D, He S, Miao H, Kempinska K, Pollock J, Chase J, et al. Pharmacologic inhibition of the menin-MLL interaction blocks progression of MLL leukemia in vivo. Cancer Cell. 2015;27:589\u2013602.","journal-title":"Cancer Cell"},{"key":"382_CR29","doi-asserted-by":"crossref","unstructured":"K\u00fchn MWM, Song E, Feng Z, Sinha A, Chen C, Deshpande AJ, et al. Targeting chromatin regulators inhibits leukemogenic gene expression in NPM1 mutant leukemia. Cancer Discov. 2016;6:1166\u201381.","DOI":"10.1158\/2159-8290.CD-16-0237"},{"key":"382_CR30","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ccr.2009.09.036","volume":"16","author":"O Bereshchenko","year":"2009","unstructured":"Bereshchenko O, Mancini E, Moore S, Bilbao D, M\u00e5nsson R, Luc S, et al. Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C\/EBP\u03b1 Mutant AML. Cancer Cell. 2009;16:390\u2013400.","journal-title":"Cancer Cell"},{"key":"382_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ccr.2013.09.018","volume":"24","author":"H Zhang","year":"2013","unstructured":"Zhang H, Alberich-Jorda M, Amabile G, Yang H, Staber PB, Di Ruscio A, et al. Sox4 is a key oncogenic target in C\/EBP\u03b1 mutant acute myeloid leukemia. Cancer Cell. 2013;24:575\u201388.","journal-title":"Cancer Cell"},{"key":"382_CR32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.exphem.2015.04.002","volume":"43","author":"SK Nandakumar","year":"2015","unstructured":"Nandakumar SK, Johnson K, Throm SL, Pestina TI, Neale G, Persons DA. Low-level GATA2 overexpression promotes myeloid progenitor self-renewal and blocks lymphoid differentiation in mice. Exp Hematol. 2015;43:565\u201377.","journal-title":"Exp Hematol"},{"key":"382_CR33","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1182\/blood-2011-12-397083","volume":"120","author":"M Luesink","year":"2017","unstructured":"Luesink M, Hollink IHIM, van der Velden VH, Knops RHJN, Boezeman JBM, Haas D, et al. High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia. Blood. 2017;120:2064\u201376.","journal-title":"Blood"},{"key":"382_CR34","doi-asserted-by":"crossref","unstructured":"Johnson KD, Kong G, Gao X, Chang YI, Hewitt KJ, Sanalkumar R, et al. Cis-regulatory mechanisms governing stem and progenitor cell transitions. Sci Adv. 2015;1:e1500503.","DOI":"10.1126\/sciadv.1500503"},{"key":"382_CR35","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.celrep.2014.04.015","volume":"7","author":"BP Mishra","year":"2014","unstructured":"Mishra BP, Zaffuto KM, Artinger EL, Org T, Mikkola HKA, Cheng C, et al. The histone methyltransferase activity of MLL1 is dispensable for hematopoiesis and leukemogenesis. Cell Rep. 2014;7:1239\u201347.","journal-title":"Cell Rep"},{"key":"382_CR36","doi-asserted-by":"publisher","first-page":"44669","DOI":"10.1074\/jbc.M107179200","volume":"276","author":"JH Lee","year":"2001","unstructured":"Lee JH, Voo KS, Skalnik DG. Identification and characterization of the DNA binding domain of CpG-binding protein. J Biol Chem. 2001;276:44669\u201376.","journal-title":"J Biol Chem"},{"key":"382_CR37","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1126\/science.288.5470.1422","volume":"288","author":"RH Jacobson","year":"2000","unstructured":"Jacobson RH, Ladurner AG, King DS, Tjian R. Structure and function of a human TAFII250 double bromodomain module. Science. 2000;288:1422\u20135.","journal-title":"Science"},{"key":"382_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jmb.2010.05.005","volume":"400","author":"PY Chang","year":"2010","unstructured":"Chang P-Y, Hom RA, Musselman CA, Zhu L, Kuo A, Gozani O, et al. Binding of the MLL PHD3 finger to histone H3K4me3 is required for MLL-dependent gene transcription. J Mol Biol. 2010;400:137\u201344.","journal-title":"J Mol Biol"},{"key":"382_CR39","doi-asserted-by":"publisher","first-page":"40690","DOI":"10.1074\/jbc.M110.172783","volume":"285","author":"J Grembecka","year":"2010","unstructured":"Grembecka J, Belcher AM, Hartley T, Cierpicki T. Molecular basis of the mixed lineage leukemia-menin interaction: implications for targeting mixed lineage leukemias. J Biol Chem. 2010;285:40690\u20138.","journal-title":"J Biol Chem"},{"key":"382_CR40","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1101\/gad.1111603","volume":"17","author":"PM Ayton","year":"2003","unstructured":"Ayton PM, Cleary ML. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev. 2003;17:2298\u2013307.","journal-title":"Genes Dev"},{"key":"382_CR41","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1101\/gad.1602107","volume":"21","author":"P Wong","year":"2007","unstructured":"Wong P, Iwasaki M, Somervaille TCP, So CWE, So CWE, Cleary ML. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev. 2007;21:2762\u201374.","journal-title":"Genes Dev"},{"key":"382_CR42","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1200\/JCO.2008.17.5554","volume":"26","author":"G Marcucci","year":"2008","unstructured":"Marcucci G, Maharry K, Radmacher MD, Mr\u00f3zek K, Vukosavljevic T, Paschka P, et al. Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. J Clin Oncol. 2008;26:5078\u201387.","journal-title":"J Clin Oncol"},{"key":"382_CR43","doi-asserted-by":"publisher","first-page":"14765","DOI":"10.1073\/pnas.0503630102","volume":"102","author":"TA Milne","year":"2005","unstructured":"Milne TA, Dou Y, Martin ME, Brock HW, Roeder RG, Hess JL. MLL associates specifically with a subset of transcriptionally active target genes. Proc Natl Acad Sci USA. 2005;102:14765\u201370.","journal-title":"Proc Natl Acad Sci USA"},{"key":"382_CR44","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ajpath.2015.10.028","volume":"186","author":"W Zhou","year":"2016","unstructured":"Zhou W, Chung YJ, Parrilla Castellar ER, Zheng Y, Chung HJ, Bandle R, et al. Far upstream element binding protein plays a crucial role in embryonic development, hematopoiesis, and stabilizing myc expression levels. Am J Pathol. 2016;186:701\u201315.","journal-title":"Am J Pathol"},{"key":"382_CR45","first-page":"24","volume":"42","author":"J Buchanan","year":"2016","unstructured":"Buchanan J, Tirado CA. A t(16;21)(p11; q22) in acute myeloid leukemia (AML) resulting in fusion of the FUS\/TLS and ERG genes: a review of the literature. J Assoc Genet Technol. 2016;42:24\u201333.","journal-title":"J Assoc Genet Technol"},{"key":"382_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-6-11","volume":"6","author":"D Nalbant","year":"2005","unstructured":"Nalbant D, Youn H, Nalbant SI, Sharma S, Cobos E, Beale EG, et al. FAM20: an evolutionarily conserved family of secreted proteins expressed in hematopoietic cells. BMC Genom. 2005;6:11.","journal-title":"BMC Genom"},{"key":"382_CR47","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/371221a0","volume":"371","author":"FY Tsai","year":"1994","unstructured":"Tsai FY, Keller G, Kuo FC, Weiss M, Chen J, Rosenblatt M, et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature. 1994;371:221\u20136.","journal-title":"Nature"},{"key":"382_CR48","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1182\/blood-2004-08-2989","volume":"106","author":"NP Rodrigues","year":"2005","unstructured":"Rodrigues NP, Janzen V, Forkert R, Dombkowski DM, Boyd AS, Orkin SH, et al. Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. Blood. 2005;106:477\u201384.","journal-title":"Blood"},{"key":"382_CR49","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.celrep.2015.05.038","volume":"11","author":"U Rabenhorst","year":"2015","unstructured":"Rabenhorst U, Thalheimer FB, Gerlach K, Kijonka M, B\u00f6hm S, Krause DS, et al. Single-stranded DNA-binding transcriptional regulator FUBP1 is essential for fetal and adult hematopoietic stem cell self-renewal. Cell Rep. 2015;11:1847\u201355.","journal-title":"Cell Rep"},{"key":"382_CR50","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1182\/blood-2002-12-3809","volume":"102","author":"N Minegishi","year":"2003","unstructured":"Minegishi N, Suzuki N, Yokomizo T, Pan X, Fujimoto T, Takahashi S, et al. Expression and domain-specific function of GATA-2 during differentiation of the hematopoietic precursor cells in midgestation mouse embryos. Blood. 2003;102:896\u2013905.","journal-title":"Blood"},{"key":"382_CR51","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood.V93.2.488","volume":"93","author":"DA Persons","year":"1999","unstructured":"Persons DA, Allay JA, Allay ER, Ashmun RA, Orlic D, Jane SM, et al. Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis. Blood. 1999;93:488\u201399.","journal-title":"Blood"},{"key":"382_CR52","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1046\/j.1365-2141.2001.02736.x","volume":"113","author":"S Fujimaki","year":"2001","unstructured":"Fujimaki S, Harigae H, Sugawara T, Takasawa N, Sasaki T, Kaku M. Decreased expression of transcription factor GATA-2 in haematopoietic stem cells in patients with aplastic anaemia. Br J Haematol. 2001;113:52\u20137.","journal-title":"Br J Haematol"},{"key":"382_CR53","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.exphem.2009.09.005","volume":"37","author":"Y Xu","year":"2009","unstructured":"Xu Y, Takahashi Y, Wang Y, Hama A, Nishio N, Muramatsu H, et al. Downregulation of GATA-2 and overexpression of adipogenic gene-PPARgamma in mesenchymal stem cells from patients with aplastic anemia. Exp Hematol. 2009;37:1393\u20139.","journal-title":"Exp Hematol"},{"key":"382_CR54","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1073\/pnas.0711824105","volume":"105","author":"SJ Zhang","year":"2008","unstructured":"Zhang S-J, Ma L-Y, Huang Q-H, Li G, Gu B-W, Gao X-D, et al. Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc Natl Acad Sci USA. 2008;105:2076\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"382_CR55","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/leu.2011.235","volume":"26","author":"C Vicente","year":"2012","unstructured":"Vicente C, Vazquez I, Conchillo A, Garc\u00eda-S\u00e1nchez MA, Marcotegui N, Fuster O, et al. Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalities. Leukemia. 2012;26:550\u20134.","journal-title":"Leukemia"},{"key":"382_CR56","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/pcmr.12671","volume":"31","author":"J Nguyen","year":"2018","unstructured":"Nguyen J, Alexander T, Jiang H, Hill N, Abdullaev Z, Pack SD, et al. Melanoma in patients with GATA2 deficiency. Pigment Cell Melanoma Res. 2018;31:337\u201340.","journal-title":"Pigment Cell Melanoma Res"},{"key":"382_CR57","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/leu.2017.196","volume":"32","author":"CE Chong","year":"2018","unstructured":"Chong C-E, Venugopal P, Stokes PH, Lee YK, Brautigan PJ, Yeung DTO, et al. Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes. Leukemia. 2018;32:194\u2013202.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-019-0382-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-019-0382-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-019-0382-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:36:44Z","timestamp":1684618604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-019-0382-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["382"],"URL":"https:\/\/doi.org\/10.1038\/s41375-019-0382-3","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"assertion":[{"value":"2 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"P.V. received honoraria from Novartis, Incyte, Celgene, and Pfizer and a research grant from Incyte. J.G. receives research support from Kura Oncology, Inc and has an equity ownership in the company. Other coauthors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}